Aktieselskabet Schouw & Co.
9.12.2024 15:00:00 CET | Globenewswire | Press release
Schouw & Co. share buy-back programme, week 49 2024
Schouw & Co. share buy-back programme, week 49 2024
On 4 March 2024, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 13 of 1 March 2024. Under the programme, Schouw & Co. will acquire shares for up to DKK 200 million during the period 4 March 2024 to 31 December 2024.
The buy-back will be structured in accordance with Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (MAR) and the Commission’s delegated regulation (EU) 2016/1052 of 8 March 2016 (“Safe Harbour” rules).
| Trading day | No. of shares | Average price | Amount | ||
| Accumulated until 29/11/2024 | 324,887 | 558.67 | 181,504,498 | ||
| Monday, 2 December 2024 | 2,000 | 558.64 | 1,117,280 | ||
| Tuesday, 3 December 2024 | 2,000 | 553.11 | 1,106,220 | ||
| Wednesday, 4 December 2024 | 2,000 | 551.69 | 1,103,380 | ||
| Thursday, 5 December 2024 | 2,000 | 550.12 | 1,100,240 | ||
| Friday, 6 December 2024 | 2,000 | 551.42 | 1,102,840 | ||
| In the period 2/12/2024 - 6/12/2024 | 10,000 | 553.00 | 5,529,960 | ||
| Accumulated 4/3/2024 - 6/12/2024 | 334,887 | 558.50 | 187,034,458 | ||
| Following the above transactions Schouw & Co. holds a total of 1,945,813 treasury shares corresponding to 7.78% of the total share capital of 25,000,000 shares. | |||||
Aktieselskabet Schouw & Co.
Jørgen Dencker Wisborg, Chairman
Jens Bjerg Sørensen, President, telephone number +45 86 11 22 22
Attachments
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Alkane Resources Limited30.3.2026 00:16:17 CEST | Press release
Alkane Executes $110 Million Revolving Credit Facility
Fast Ejendom Danmark29.3.2026 18:17:55 CEST | Pressemeddelelse
Aktietilbagekøbsprogram
Newcap Holdings29.3.2026 12:19:20 CEST | Pressemeddelelse
NewCap Holding A/S har indgået en aftale, betinget af underskrivelse af endelige aftaledokumenter m.v., om erhvervelse af dansk selskab indenfor compliance og risikostyringsservices – Intern viden
Novartis Pharma AG29.3.2026 07:15:00 CEST | Press release
Novartis IgAN data in New England Journal of Medicine show Fabhalta® slowed kidney function decline by 49.3%
Biogen Inc.28.3.2026 20:00:00 CET | Press release
Biogen Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting, Showing a Significant Reduction in Skin Disease Activity
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom